70 related articles for article (PubMed ID: 32900773)
1. YAP-Mediated Repression of HRK Regulates Tumor Growth, Therapy Response, and Survival Under Tumor Environmental Stress in Neuroblastoma.
Shim J; Lee JY; Jonus HC; Arnold A; Schnepp RW; Janssen KM; Maximov V; Goldsmith KC
Cancer Res; 2020 Nov; 80(21):4741-4753. PubMed ID: 32900773
[TBL] [Abstract][Full Text] [Related]
2. YAP1 Mediates Resistance to MEK1/2 Inhibition in Neuroblastomas with Hyperactivated RAS Signaling.
Coggins GE; Farrel A; Rathi KS; Hayes CM; Scolaro L; Rokita JL; Maris JM
Cancer Res; 2019 Dec; 79(24):6204-6214. PubMed ID: 31672841
[TBL] [Abstract][Full Text] [Related]
3. The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of
Pilgrim AA; Jonus HC; Ho A; Cole AC; Shim J; Goldsmith KC
Oncoimmunology; 2023; 12(1):2240678. PubMed ID: 37554309
[TBL] [Abstract][Full Text] [Related]
4. Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma.
Zhang X; Yu K; Ma L; Qian Z; Tian X; Miao Y; Niu Y; Xu X; Guo S; Yang Y; Wang Z; Xue X; Gu C; Fang W; Sun J; Yu Y; Wang J
Theranostics; 2021; 11(12):5650-5674. PubMed ID: 33897873
[No Abstract] [Full Text] [Related]
5. YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors.
Marti P; Stein C; Blumer T; Abraham Y; Dill MT; Pikiolek M; Orsini V; Jurisic G; Megel P; Makowska Z; Agarinis C; Tornillo L; Bouwmeester T; Ruffner H; Bauer A; Parker CN; Schmelzle T; Terracciano LM; Heim MH; Tchorz JS
Hepatology; 2015 Nov; 62(5):1497-510. PubMed ID: 26173433
[TBL] [Abstract][Full Text] [Related]
6. A role for Hippo/YAP-signaling in FGF-induced lens epithelial cell proliferation and fibre differentiation.
Dawes LJ; Shelley EJ; McAvoy JW; Lovicu FJ
Exp Eye Res; 2018 Apr; 169():122-133. PubMed ID: 29355736
[TBL] [Abstract][Full Text] [Related]
7. Circ0106714 inhibits tumorigenesis of colorectal cancer by sponging miR-942-5p and releasing DLG2 via Hippo-YAP signaling.
Li S; Yan G; Liu W; Li C; Wang X
Mol Carcinog; 2020 Dec; 59(12):1323-1342. PubMed ID: 33128289
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma.
Hart LS; Rader J; Raman P; Batra V; Russell MR; Tsang M; Gagliardi M; Chen L; Martinez D; Li Y; Wood A; Kim S; Parasuraman S; Delach S; Cole KA; Krupa S; Boehm M; Peters M; Caponigro G; Maris JM
Clin Cancer Res; 2017 Apr; 23(7):1785-1796. PubMed ID: 27729458
[No Abstract] [Full Text] [Related]
9. HDAC Inhibition Enhances the
Faião-Flores F; Emmons MF; Durante MA; Kinose F; Saha B; Fang B; Koomen JM; Chellappan SP; Maria-Engler SS; Rix U; Licht JD; Harbour JW; Smalley KSM
Clin Cancer Res; 2019 Sep; 25(18):5686-5701. PubMed ID: 31227503
[TBL] [Abstract][Full Text] [Related]
10. Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer.
Yun MR; Choi HM; Lee YW; Joo HS; Park CW; Choi JW; Kim DH; Kang HN; Pyo KH; Shin EJ; Shim HS; Soo RA; Yang JC; Lee SS; Chang H; Kim MH; Hong MH; Kim HR; Cho BC
EMBO Mol Med; 2019 Dec; 11(12):e10581. PubMed ID: 31633304
[TBL] [Abstract][Full Text] [Related]
11.
Valencia-Sama I; Ladumor Y; Kee L; Adderley T; Christopher G; Robinson CM; Kano Y; Ohh M; Irwin MS
Cancer Res; 2020 Aug; 80(16):3413-3423. PubMed ID: 32586982
[TBL] [Abstract][Full Text] [Related]
12. REGγ Controls Hippo Signaling and Reciprocal NF-κB-YAP Regulation to Promote Colon Cancer.
Wang Q; Gao X; Yu T; Yuan L; Dai J; Wang W; Chen G; Jiao C; Zhou W; Huang Q; Cui L; Zhang P; Moses RE; Yang J; Chen F; Fu J; Xiao J; Li L; Dang Y; Li X
Clin Cancer Res; 2018 Apr; 24(8):2015-2025. PubMed ID: 29437787
[No Abstract] [Full Text] [Related]
13. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes.
Mizuno T; Murakami H; Fujii M; Ishiguro F; Tanaka I; Kondo Y; Akatsuka S; Toyokuni S; Yokoi K; Osada H; Sekido Y
Oncogene; 2012 Dec; 31(49):5117-22. PubMed ID: 22286761
[TBL] [Abstract][Full Text] [Related]
14. Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC).
Hsu PC; Jablons DM; Yang CT; You L
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387256
[TBL] [Abstract][Full Text] [Related]
15. Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth.
Xu M; Chen X; Chen N; Nie L; Li X; Li Q; Zeng H; Zhou Q
Am J Pathol; 2013 Jan; 182(1):84-95. PubMed ID: 23159945
[TBL] [Abstract][Full Text] [Related]
16. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.
Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ
Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291
[TBL] [Abstract][Full Text] [Related]
17. Astrocytic YAP Promotes the Formation of Glia Scars and Neural Regeneration after Spinal Cord Injury.
Xie C; Shen X; Xu X; Liu H; Li F; Lu S; Gao Z; Zhang J; Wu Q; Yang D; Bao X; Zhang F; Wu S; Lv Z; Zhu M; Xu D; Wang P; Cao L; Wang W; Yuan Z; Wang Y; Li Z; Teng H; Huang Z
J Neurosci; 2020 Mar; 40(13):2644-2662. PubMed ID: 32066583
[TBL] [Abstract][Full Text] [Related]
18. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.
Yang Y; Del Re DP; Nakano N; Sciarretta S; Zhai P; Park J; Sayed D; Shirakabe A; Matsushima S; Park Y; Tian B; Abdellatif M; Sadoshima J
Circ Res; 2015 Oct; 117(10):891-904. PubMed ID: 26333362
[TBL] [Abstract][Full Text] [Related]
19. Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma.
Chlenski A; Park C; Dobratic M; Salwen HR; Budke B; Park JH; Miller R; Applebaum MA; Wilkinson E; Nakamura Y; Connell PP; Cohn SL
Mol Cancer Ther; 2019 Mar; 18(3):507-516. PubMed ID: 30674566
[TBL] [Abstract][Full Text] [Related]
20. A Ca
Dang DK; Makena MR; Llongueras JP; Prasad H; Ko M; Bandral M; Rao R
Mol Cancer Res; 2019 Aug; 17(8):1735-1747. PubMed ID: 31076498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
